ATH alterity therapeutics limited

Ann: Investor presentation - Biotech Showcase, page-7

  1. 3,036 Posts.
    lightbulb Created with Sketch. 1120
    The other detail ;  about PBT2   " •Evaluating non‐neurological indications for further  development ".  IMO one area could be:  light chain amyloidosis in which Cherny at al ( italian group) demonstrated clear quick effect in an animal model.  
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $91.27M
Open High Low Value Volume
1.0¢ 1.1¢ 0.9¢ $103.8K 10.38M

Buyers (Bids)

No. Vol. Price($)
43 15072426 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 423663 2
View Market Depth
Last trade - 16.17pm 30/06/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.